4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average.
Left:
||||
Free cash flow yield
Latest
-46.05%
↓ 296% below average
Average (7y)
-11.61%
Historical baseline
Range
High:1.28%
Low:-46.05%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -46.05% | -364.7% |
| 2023 | -9.91% | +27.5% |
| 2022 | -13.67% | -6.3% |
| 2021 | -12.86% | -174.0% |
| 2020 | -4.69% | -26.2% |
| 2019 | -3.72% | -13.2% |
| 2018 | -3.29% | -357.7% |
| 2017 | 1.28% | - |